328 related articles for article (PubMed ID: 22807686)
1. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers.
Li S; Qian J; Yang Y; Zhao W; Dai J; Bei JX; Foo JN; McLaren PJ; Li Z; Yang J; Shen F; Liu L; Yang J; Li S; Pan S; Wang Y; Li W; Zhai X; Zhou B; Shi L; Chen X; Chu M; Yan Y; Wang J; Cheng S; Shen J; Jia W; Liu J; Yang J; Wen Z; Li A; Zhang Y; Zhang G; Luo X; Qin H; Chen M; Wang H; Jin L; Lin D; Shen H; He L; de Bakker PI; Wang H; Zeng YX; Wu M; Hu Z; Shi Y; Liu J; Zhou W
PLoS Genet; 2012; 8(7):e1002791. PubMed ID: 22807686
[TBL] [Abstract][Full Text] [Related]
2. Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci in a Chinese population.
Chen K; Shi W; Xin Z; Wang H; Zhu X; Wu X; Li Z; Li H; Liu Y
PLoS One; 2013; 8(10):e77315. PubMed ID: 24204805
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study.
Wen J; Song C; Jiang D; Jin T; Dai J; Zhu L; An J; Liu Y; Ma S; Qin N; Liang C; Chen J; Jiang Y; Yang L; Liu J; Liu L; Geng T; Chen C; Jiang J; Chen J; Zhu F; Zhu Y; Yu L; Shen H; Zhai X; Xu J; Hu Z
Sci Rep; 2015 Nov; 5():16489. PubMed ID: 26568165
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome-wide association study for persistent hepatitis B virus infection and related hepatocellular carcinoma.
Han J; Chen C; Wang C; Qin N; Huang M; Ma Z; Zhu M; Dai J; Jiang Y; Ma H; Jin G; Shen H; Hu Z
Liver Int; 2020 Sep; 40(9):2117-2127. PubMed ID: 32574393
[TBL] [Abstract][Full Text] [Related]
5. Genetic variations in STAT4,C2,HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis.
Jiang DK; Ma XP; Wu X; Peng L; Yin J; Dan Y; Huang HX; Ding DL; Zhang LY; Shi Z; Zhang P; Yu H; Sun J; Lilly Zheng S; Deng G; Xu J; Liu Y; Guo J; Cao G; Yu L
Sci Rep; 2015 Nov; 5():16278. PubMed ID: 26538132
[TBL] [Abstract][Full Text] [Related]
6. Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma.
Jiang D; Deng J; Dong C; Ma X; Xiao Q; Zhou B; Yang C; Wei L; Conran C; Zheng SL; Ng IO; Yu L; Xu J; Sham PC; Qi X; Hou J; Ji Y; Cao G; Li M
BMC Cancer; 2020 May; 20(1):403. PubMed ID: 32393195
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
[TBL] [Abstract][Full Text] [Related]
8. Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population.
Kim LH; Cheong HS; Namgoong S; Kim JO; Kim JH; Park BL; Cho SW; Park NH; Cheong JY; Koh I; Shin HD; Kim YJ
Infect Genet Evol; 2015 Jul; 33():72-6. PubMed ID: 25913043
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
Jiang DK; Sun J; Cao G; Liu Y; Lin D; Gao YZ; Ren WH; Long XD; Zhang H; Ma XP; Wang Z; Jiang W; Chen TY; Gao Y; Sun LD; Long JR; Huang HX; Wang D; Yu H; Zhang P; Tang LS; Peng B; Cai H; Liu TT; Zhou P; Liu F; Lin X; Tao S; Wan B; Sai-Yin HX; Qin LX; Yin J; Liu L; Wu C; Pei Y; Zhou YF; Zhai Y; Lu PX; Tan A; Zuo XB; Fan J; Chang J; Gu X; Wang NJ; Li Y; Liu YK; Zhai K; Zhang H; Hu Z; Liu J; Yi Q; Xiang Y; Shi R; Ding Q; Zheng W; Shu XO; Mo Z; Shugart YY; Zhang XJ; Zhou G; Shen H; Zheng SL; Xu J; Yu L
Nat Genet; 2013 Jan; 45(1):72-5. PubMed ID: 23242368
[TBL] [Abstract][Full Text] [Related]
10. HLA-DQA1 & DQB1 variants associated with hepatitis B virus-related chronic hepatitis, cirrhosis & hepatocellular carcinoma.
Karra VK; Chowdhury SJ; Ruttala R; Gumma PK; Polipalli SK; Chakravarti A; Kar P
Indian J Med Res; 2018 Jun; 147(6):573-580. PubMed ID: 30168489
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.
Sawai H; Nishida N; Khor SS; Honda M; Sugiyama M; Baba N; Yamada K; Sawada N; Tsugane S; Koike K; Kondo Y; Yatsuhashi H; Nagaoka S; Taketomi A; Fukai M; Kurosaki M; Izumi N; Kang JH; Murata K; Hino K; Nishina S; Matsumoto A; Tanaka E; Sakamoto N; Ogawa K; Yamamoto K; Tamori A; Yokosuka O; Kanda T; Sakaida I; Itoh Y; Eguchi Y; Oeda S; Mochida S; Yuen MF; Seto WK; Poovorawan Y; Posuwan N; Mizokami M; Tokunaga K
Sci Rep; 2018 May; 8(1):7958. PubMed ID: 29784950
[TBL] [Abstract][Full Text] [Related]
12. Variants identified by hepatocellular carcinoma and chronic hepatitis B virus infection susceptibility GWAS associated with survival in HBV-related hepatocellular carcinoma.
Li C; Bi X; Huang Y; Zhao J; Li Z; Zhou J; Zhang M; Huang Z; Zhao H; Cai J
PLoS One; 2014; 9(7):e101586. PubMed ID: 24987808
[TBL] [Abstract][Full Text] [Related]
13. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
14. UBE2L3, a susceptibility gene that plays oncogenic role in hepatitis B-related hepatocellular carcinoma.
Liu Y; Song C; Ni H; Jiao W; Gan W; Dong X; Liu J; Zhu L; Zhai X; Hu Z; Li J
J Viral Hepat; 2018 Nov; 25(11):1363-1371. PubMed ID: 29969176
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus persistent infection-related single nucleotide polymorphisms in HLA regions are associated with viral load in hepatoma families.
Hsieh AR; Fann CSJ; Lin HC; Tai J; Hsieh SY; Tai DI
World J Gastroenterol; 2021 Oct; 27(37):6262-6276. PubMed ID: 34712031
[TBL] [Abstract][Full Text] [Related]
16. Locus 5p13.1 may be associated with the selection of cancer-related HBV core promoter mutations.
Chen QY; Hu YL; Wang XY; Harrison TJ; Wang C; Hu LP; Yang QL; Ren CC; Jia HH; Fang AZ
Int J Med Sci; 2019; 16(7):990-997. PubMed ID: 31341412
[No Abstract] [Full Text] [Related]
17. Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma.
Liu Z; Song C; Wen J; Xu L; Liu Y; Zhu J; Zhu L; Hu Z; Ma H; Liu L
Oncotarget; 2016 Jul; 7(28):44076-44083. PubMed ID: 27286450
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers.
Zhang H; Zhai Y; Hu Z; Wu C; Qian J; Jia W; Ma F; Huang W; Yu L; Yue W; Wang Z; Li P; Zhang Y; Liang R; Wei Z; Cui Y; Xie W; Cai M; Yu X; Yuan Y; Xia X; Zhang X; Yang H; Qiu W; Yang J; Gong F; Chen M; Shen H; Lin D; Zeng YX; He F; Zhou G
Nat Genet; 2010 Sep; 42(9):755-8. PubMed ID: 20676096
[TBL] [Abstract][Full Text] [Related]
19. Genome-Wide Association Study Identifies a New Locus at 7q21.13 Associated with Hepatitis B Virus-Related Hepatocellular Carcinoma.
Li Y; Zhai Y; Song Q; Zhang H; Cao P; Ping J; Liu X; Guo B; Liu G; Song J; Zhang Y; Yang A; Yan H; Yang L; Cui Y; Ma Y; Xing J; Shen X; Liu T; Zhang H; An J; Bei JX; Jia W; Kang L; Liu L; Yuan D; Hu Z; Shen H; Lu L; Wang X; Li H; He F; Zhang H; Zhou G
Clin Cancer Res; 2018 Feb; 24(4):906-915. PubMed ID: 29246937
[No Abstract] [Full Text] [Related]
20. Host genetic variants influencing the clinical course of hepatitis B virus infection.
Matsuura K; Isogawa M; Tanaka Y
J Med Virol; 2016 Mar; 88(3):371-9. PubMed ID: 26255971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
